GlassScriptPhysician profile
Vanessa J Biggs
NPI 1235118282
$2,852.63
in general payments reported to CMS, 2019-2025
38 companies · $531 in 2025
The $531 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $600 · 2020: $121 · 2021: $248 · 2022: $726 · 2023: $421 · 2024: $207 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $362.80 | 2019-2023 | Lo Loestrin Fe |
| Channel Medsystems, INC. | $214.98 | 2022-2023 | |
| Astellas Pharma US INC | $208.68 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $181.39 | 2022-2025 | |
| Hologic Sales and Service, LLC | $178.41 | 2022-2024 | Aptima, Acessa Provu System |
| Evofem Biosciences, INC. | $150.08 | 2021-2025 | Phexxi, Phexx, Solosec |
| Aspira Women'S Health INC | $148.03 | 2022-2024 | Ova1 |
| Amgen INC. | $101.40 | 2019-2025 | Evenity |
| Radius Health, INC. | $94.29 | 2019-2023 | Tymlos |
| Biogen, INC. | $93.05 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $87.52 | 2019-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $86.87 | 2019-2024 | |
| Therapeuticsmd, INC. | $76.84 | 2019-2022 | |
| Pfizer INC. | $70.02 | 2021-2022 | |
| Duchesnay USA Incorporated | $68.57 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $64.71 | 2021-2022 | |
| Bsn Medical INC | $56.85 | 2025 | |
| Coopersurgical, INC. | $54.39 | 2019-2020 | |
| Ethicon US, LLC | $49.49 | 2023 | Dermabond Prineo, Vistaseal, Dermabond |
| Mylan Pharmaceuticals INC. | $45.10 | 2021-2022 | |
| Avion Pharmaceuticals | $44.36 | 2019-2022 | |
| Allergan, INC. | $38.89 | 2019 | |
| Medela LLC | $38.82 | 2019 | |
| Millicent US INC | $38.25 | 2019-2025 | Femlyv |
| Exact Sciences Corporation | $35.24 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $29.56 | 2019-2024 | Gardasil 9, Gardasil |
| Minerva Surgical, INC | $29.37 | 2025 | |
| Avanos Medical | $29.34 | 2019 | |
| Daiichi Sankyo INC. | $28.95 | 2019 | |
| Lilly USA, LLC | $27.69 | 2019 | |
| Solventum Corporation | $23.61 | 2025 | Prevena |
| Boston Scientific Corporation | $18.53 | 2024 | Ekosonic |
| Amag Pharmaceuticals, INC. | $14.96 | 2019 | |
| Scynexis, INC. | $13.06 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.59 | 2019 | |
| Glaxosmithkline, LLC. | $12.43 | 2019 | |
| Organon LLC | $11.97 | 2022 | |
| Vertical Pharmaceuticals, LLC | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Biggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.